Murdock Charitable Trust (L.H., N.D.P.), NIH grants 2P50GM076547 (L.H., N.D.P.), P30ES017885 (G.S.O.), U24CA2210967 (G.S.O.), RC2HG005805 (R.L.M.), and Arivale
Johnson RJ, Kivlighn SD, Kim YG, Suga S, Fogo AB
US-based synthesis and fulfillment cut shipping time for domestic labs
Therefore, the objective of the present review was to systematically map out the body of existing literature on therapeutic controversies over the use of antioxidant supplements during cancer treatment in order to identify type of antioxidant supplements that have been commonly given for patients, treatment outcomes reported, summarize the safety and effectiveness of these supplements during cancer treatment in the various clinical settings and opportunities for further research